Galmed Pharmaceuticals Ltd
(NAS:GLMD)
$
0.3104
0.0217 (7.52%)
Market Cap: 1.97 Mil
Enterprise Value: -10.63 Mil
PE Ratio: 0
PB Ratio: 0.15
GF Score: 36/100 Galmed Pharmaceuticals Ltd (GLMD) Transcripts
- Q4 2021 Galmed Pharmaceuticals Ltd Earnings Call TranscriptMay 02, 2022$18.3 (-26.51%)Earnings
- Q3 2021 Galmed Pharmaceuticals Ltd Earnings Call TranscriptNov 08, 2021$44.85 (+6.79%)Earnings
- Q2 2021 Galmed Pharmaceuticals Ltd Earnings Call TranscriptAug 05, 2021$42.9 (+4.38%)Earnings
- Q1 2021 Galmed Pharmaceuticals Ltd Earnings Call TranscriptMay 13, 2021$33.6 (-8.20%)Earnings
- Q4 2020 Galmed Pharmaceuticals Ltd Earnings Call TranscriptMar 18, 2021$51.3 (-2.01%)Earnings
- Galmed Pharmaceuticals Ltd KOL Symposium and Pipeline Update TranscriptJan 26, 2021
- Q3 2020 Galmed Pharmaceuticals Ltd Earnings Call TranscriptNov 12, 2020$47.55 (-5.65%)Earnings
- Q2 2020 Galmed Pharmaceuticals Ltd Earnings Call TranscriptAug 06, 2020$69.15 (-7.24%)Earnings
- Q1 2020 Galmed Pharmaceuticals Ltd Earnings Call TranscriptMay 14, 2020$76.2 (+2.21%)Earnings
- Q4 2019 Galmed Pharmaceuticals Ltd Earnings Call TranscriptMar 12, 2020$50.85 (-19.48%)Earnings
- Q3 2019 Galmed Pharmaceuticals Ltd Earnings Call TranscriptNov 06, 2019$64.05 (-10.11%)Earnings
- Q2 2019 Galmed Pharmaceuticals Ltd Earnings Call TranscriptAug 05, 2019Earnings
- 1